Search Tag: Metabolic Dysfunction–Associated Steatohepatitis

2025 07 May

New research published in the New England Journal of Medicine reveals that semaglutide effectively treats liver disease in nearly two-thirds of patients, offering new hope for those with metabolic dysfunction-associated steatohepatitis (MASH), a severe form of liver disease.   MASH is a progressive form of Metabolic dysfunction-associated steatotic...Read more